documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
49 rows where docket_id = "FDA-2005-N-0453" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
- Supporting & Related Material 25
- Other 22
- Notice 2
agency_id 1
- FDA 49
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2005-N-0453-0055 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | DSM Nutritional Products June 7 2019 Meeting Minutes | Other | Minutes | 2019-08-28T04:00:00Z | 2019 | 8 | 2019-08-28T04:00:00Z | 2019-08-28T18:40:49Z | 0 | 0 | 0900006483ed5517 | ||
| FDA-2005-N-0453-0054 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Letter from FDA CDER to DSM Nutritional Products LLC | Other | Letter(s) | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T04:00:00Z | 2019-06-05T15:49:14Z | 0 | 0 | 0900006483ced582 | ||
| FDA-2005-N-0453-0053 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Request for Type C Meeting from DSM | Other | Request | 2019-05-01T04:00:00Z | 2019 | 5 | 2019-05-01T04:00:00Z | 2019-05-01T18:52:26Z | 0 | 0 | 0900006483c25323 | ||
| FDA-2005-N-0453-0052 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Request for Non Public Meeting from DSM Nutritional Products | Other | Request | 2019-01-29T05:00:00Z | 2019 | 1 | 2019-01-29T05:00:00Z | 2019-01-29T18:45:00Z | 0 | 0 | 0900006483a2238b | ||
| FDA-2005-N-0453-0051 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | MEMORANDUM OF MEETING MINUTES - BASF Bemotrizinol and Bisoctrizole October 12, 2017 | Other | Memorandum | 2017-11-15T05:00:00Z | 2017 | 11 | 2017-11-15T05:00:00Z | 2017-11-15T17:48:04Z | 0 | 0 | 0900006482c7b23a | ||
| FDA-2005-N-0453-0050 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Revision from BASF (Morgan, Lewis & Bockius LLP) | Other | Correction(s) | 2017-09-29T04:00:00Z | 2017 | 9 | 2017-09-29T04:00:00Z | 2017-09-29T20:24:09Z | 0 | 0 | 0900006482b8cb9f | ||
| FDA-2005-N-0453-0049 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Meeting Granted Letter BASF August 28 2017 Meeting Request | Other | Memorandum | 2017-09-19T04:00:00Z | 2017 | 9 | 2017-09-19T04:00:00Z | 2017-09-19T18:12:14Z | 0 | 0 | 0900006482b4f4e1 | ||
| FDA-2005-N-0453-0048 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Meeting Materials from BASF (Morgan, Lewis & Bockius LLP) | Other | Meeting Exhibits | 2017-09-12T04:00:00Z | 2017 | 9 | 2017-09-12T04:00:00Z | 2017-09-29T20:24:44Z | 0 | 0 | 0900006482b2bf58 | ||
| FDA-2005-N-0453-0047 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Request for Meeting from BASF (Morgan, Lewis & Bockius LLP) | Other | Request | 2017-09-01T04:00:00Z | 2017 | 9 | 2017-09-01T04:00:00Z | 2017-09-01T18:56:18Z | 0 | 0 | 0900006482b03dc4 | ||
| FDA-2005-N-0453-0045 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Letter from BASF SE (Morgan, Lewis & Bockius LLP) | Other | Letter(s) | 2015-10-15T04:00:00Z | 2015 | 10 | 2015-10-15T04:00:00Z | 2015-10-15T14:41:58Z | 0 | 0 | 0900006481ccce50 | ||
| FDA-2005-N-0453-0046 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Advice Letter from FDA CDER to Morgan, Lewis & Bockius LLP | Other | Letter(s) | 2015-10-15T04:00:00Z | 2015 | 10 | 2015-10-15T04:00:00Z | 2015-10-15T14:42:13Z | 0 | 0 | 0900006481ccce52 | ||
| FDA-2005-N-0453-0042 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Memorandum of Meeting Minutes between FDA CDER and BASF regarding Octyl Triazone and Bemotrizinol March 19, 2015 | Other | Memorandum | 2015-06-15T04:00:00Z | 2015 | 6 | 2015-06-15T04:00:00Z | 2015-06-15T17:13:28Z | 0 | 0 | 0900006481b37e78 | ||
| FDA-2005-N-0453-0043 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Memorandum of Meeting Minutes between FDA CDER and BASF Corporation regarding bisoctrizole March 20, 2015 | Other | Memorandum | 2015-06-15T04:00:00Z | 2015 | 6 | 2015-06-15T04:00:00Z | 2015-06-15T17:13:48Z | 0 | 0 | 0900006481b37e79 | ||
| FDA-2005-N-0453-0041 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Letter from FDA/CDER to Morgan, Lewis & Bockius, LLP (BASF SE) Granting Meeting Request Regarding GRASE Status of Octyl Triazone and Bemotrizinol | Other | Letter(s) | 2015-03-09T04:00:00Z | 2015 | 3 | 2015-03-09T04:00:00Z | 2015-03-09T13:44:40Z | 0 | 0 | 0900006481a33de1 | ||
| FDA-2005-N-0453-0040 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Letter from FDA/CDER to Morgan, Lewis & Bockius, LLP (BASF SE) Granting Meeting Request Regarding GRASE Status of Bisoctrizole | Other | Letter(s) | 2015-03-09T04:00:00Z | 2015 | 3 | 2015-03-09T04:00:00Z | 2015-03-09T13:40:04Z | 0 | 0 | 0900006481a33ddd | ||
| FDA-2005-N-0453-0036 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Sunscreen Feedback Letters; Notice of Availability Under the Sunscreen Innovation Act | Notice | Request for Comments | 2015-01-07T05:00:00Z | 2015 | 1 | 2015-01-07T05:00:00Z | 2015-02-24T04:59:59Z | 2015-02-24T03:08:50Z | 2015-00002 | 0 | 0 | 09000064819a9732 |
| FDA-2005-N-0453-0035 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Determination and Feedback Letter from FDA/CDER to Ciba Specialty Chemicals Corporation (Ciba) (Morgan, Lewis & Bockius LLP) re Time and Extent Application (TEA) Bemotrizinol for use in Over-the-Counter (OTC) Sunscreen | Other | Letter(s) | 2014-11-14T05:00:00Z | 2014 | 11 | 2014-11-14T05:00:00Z | 2014-11-14T20:28:13Z | 0 | 0 | 090000648192f333 | ||
| FDA-2005-N-0453-0034 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Initial Determination and Feedback Letter from FDA/CDER to Ciba Specialty Chemicals Corporation (Ciba) (Morgan, Lewis & Bockius LLP) re Time and Extent Application (TEA) Bemotrizinol for use in Over-the-Counter (OTC) Sunscreens | Other | 2014-11-13T00:00:00Z | 2014 | 11 | 2014-11-14T16:27:35Z | 0 | 1 | 090000648192d191 | ||||
| FDA-2005-N-0453-0028 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 8 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:28:36Z | 0 | 0 | 0900006481902a13 | |||
| FDA-2005-N-0453-0022 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 2 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:20:46Z | 0 | 0 | 09000064819029b7 | |||
| FDA-2005-N-0453-0025 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 5 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:22:33Z | 0 | 0 | 09000064819029bf | |||
| FDA-2005-N-0453-0031 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 11 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:30:27Z | 0 | 0 | 0900006481902a27 | |||
| FDA-2005-N-0453-0021 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 1 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:19:48Z | 0 | 0 | 090000648190293f | |||
| FDA-2005-N-0453-0024 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 4 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:22:05Z | 0 | 0 | 09000064819029bb | |||
| FDA-2005-N-0453-0027 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 7 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:27:57Z | 0 | 0 | 0900006481902a10 | |||
| FDA-2005-N-0453-0033 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Bemotrizinol Dermal Carcinogenicity Summary re Supplement from Ciba Specialty Chemicals | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:34:50Z | 0 | 0 | 0900006481902a2b | |||
| FDA-2005-N-0453-0026 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 6 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:27:16Z | 0 | 0 | 09000064819029e2 | |||
| FDA-2005-N-0453-0030 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 10 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:29:54Z | 0 | 0 | 0900006481902a25 | |||
| FDA-2005-N-0453-0023 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 3 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:21:25Z | 0 | 0 | 09000064819029b9 | |||
| FDA-2005-N-0453-0032 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 12 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:31:54Z | 0 | 0 | 0900006481902a29 | |||
| FDA-2005-N-0453-0029 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 9 of 12 re Supplement from Ciba Specialty Chemicals Corporation | Supporting & Related Material | Background Material | 2014-11-10T05:00:00Z | 2014 | 11 | 2014-11-10T16:29:14Z | 0 | 0 | 0900006481902a17 | |||
| FDA-2005-N-0453-0020 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Initial Determination and Feedback Letter from FDA/CDER to Ciba Specialty Chemicals Corporation (Ciba) (Morgan, Lewis & Bockius LLP) re Time and Extent Application (TEA) Bisoctrizole for use in Over-the-Counter (OTC) Sunscreens | Other | Letter(s) | 2014-09-03T04:00:00Z | 2014 | 9 | 2014-09-03T04:00:00Z | 2014-09-03T21:02:03Z | 0 | 0 | 090000648185a6e7 | ||
| FDA-2005-N-0453-0019 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Ciba Specialty Chemicals Corporation Correspondence with FDA Center for Drug Evaluation & Research - Electronic Letter re FDA-2005-N-0453-0002 and FDA-2005-N-0453-0003 | Other | Electronic Letter | 2014-09-03T04:00:00Z | 2014 | 9 | 2014-09-03T04:00:00Z | 2014-09-03T20:44:01Z | 0 | 0 | 09000064812be491 | ||
| FDA-2005-N-0453-0017 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Electronic Correspondence From Ciba to FDA re Confidential Information in Bisoctrizole and Bemotrizinol TEAs FDA-2005-N-0453-0001- Background | Supporting & Related Material | Background Material | 2013-05-07T04:00:00Z | 2013 | 5 | 2013-05-07T21:36:09Z | 0 | 0 | 09000064804507d4 | |||
| FDA-2005-N-0453-0018 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Electronic Correspondence From Ciba to FDA re Confidential Information in Bisoctrizole and Bemotrizinol TEAs FDA-2005-N-0453-0001 - Background | Supporting & Related Material | Background Material | 2013-05-07T04:00:00Z | 2013 | 5 | 2013-05-07T21:36:43Z | 0 | 0 | 09000064804507d9 | |||
| FDA-2005-N-0453-0016 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Skin Cancer Foundation to the Food and Drug Administration - Letter | Other | Letter(s) | 2008-08-19T04:00:00Z | 2008 | 8 | 2008-08-19T04:00:00Z | 2019-07-05T19:37:20Z | 0 | 0 | 090000648063d6c7 | ||
| FDA-2005-N-0453-0004 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Time and Extent Application (TEA) Review for Bemotrizinol [FDA-2005-N-0453-0001] - Background | Supporting & Related Material | Background Material | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-05-02T17:00:12Z | 0 | 0 | 09000064804507cf | |||
| FDA-2005-N-0453-0005 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Time and Extent Application (TEA) Review for Bisoctrizole [FDA-2005-N-0453-0001] - Background | Supporting & Related Material | Background Material | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-05-02T17:03:52Z | 0 | 0 | 09000064804507d0 | |||
| FDA-2005-N-0453-0010 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | FDA Center for Drug Evaluation and Reseach (OTC) to Ciba Specialty Chemical Corporation Letter dated 10/31/2005 [FDA-2005-N-0453-0001] - Background | Supporting & Related Material | BKG-Background Material | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-05-02T17:12:19Z | 0 | 0 | 09000064804507d8 | |||
| FDA-2005-N-0453-0003 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Ciba Specialty Chemicals Corporation - [Bemotrizinol] - Supplement | Other | Supplement (SUP) | 2008-06-13T04:00:00Z | 2008 | 6 | 2008-06-13T04:00:00Z | 2013-05-07T21:31:57Z | 0 | 0 | 09000064804507e3 | ||
| FDA-2005-N-0453-0013 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Time and Extend Application Bemotrizinol [Product Labeling] [FDA-2005-N-0453-0001] - Background | Supporting & Related Material | Background Material | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-05-02T17:31:03Z | 0 | 0 | 09000064804507dc | |||
| FDA-2005-N-0453-0012 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Time and Extend Application Bemotrizinol - [Appendices] [FDA-2005-N-0453-0001] - Background | Supporting & Related Material | Background Material | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-05-02T17:29:25Z | 0 | 0 | 09000064804507db | |||
| FDA-2005-N-0453-0009 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Time and Extend Application Bisoctrizole [Product Labeling] [FDA-2005-N-0453-0001] - Background | Supporting & Related Material | Background Material | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-05-02T17:10:59Z | 0 | 0 | 09000064804507d7 | |||
| FDA-2005-N-0453-0011 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Time and Extend Application Bemotrizinol - [Prepared to support the Inclusion of Bemotrizinol into FDA’s Monograph for Sunscreen Drug Products] [FDA-2005-N-0453-0001] - Background | Supporting & Related Material | Background Material | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-05-02T17:15:05Z | 0 | 0 | 09000064804507da | |||
| FDA-2005-N-0453-0007 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Time and Extend Application Bisoctrizole - [Prepared to support the Inclusion of Bisoctrizole into FDA’s Monograph for Sunscreen Drug Products] [FDA-2005-N-0453-0001] - Background | Supporting & Related Material | Background Material | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-05-02T17:06:46Z | 0 | 0 | 09000064804507d5 | |||
| FDA-2005-N-0453-0008 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Time and Extend Application Bisoctrizole - [Appendices] [FDA-2005-N-0453-0001] - Background | Supporting & Related Material | Background Material | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-05-02T17:09:09Z | 0 | 0 | 09000064804507d6 | |||
| FDA-2005-N-0453-0002 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Ciba Specialty Chemicals Corporation re Bisoctrizole - Supplement | Other | Supplement (SUP) | 2008-06-13T04:00:00Z | 2008 | 6 | 2008-06-13T04:00:00Z | 2013-05-07T21:31:02Z | 0 | 0 | 09000064804507e2 | ||
| FDA-2005-N-0453-0006 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | FDA Center for Drug Evaluation and Reseach (OTC) to Ciba Specialty Chemical Corporation Letter dated 10/31/2005 [FDA-2005-N-0453-0001] - Background | Supporting & Related Material | Background Material | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-05-02T17:03:01Z | 0 | 0 | 09000064804507d3 | |||
| FDA-2005-N-0453-0001 | FDA | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 | Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients | Notice | NRD-Notice of Requesting Data, Info, & Views | 2005-12-02T05:00:00Z | 2005 | 12 | 2005-12-05T05:00:00Z | 2006-03-07T04:59:59Z | 2009-12-30T19:54:55Z | 0 | 0 | 09000064804507c9 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;